EL-SHIN Therapy for Depressive Symptoms
Enhancing the Efficacy of Depression and Low Mood Treatment: A Novel Adjunctive Approach
1 other identifier
interventional
80
1 country
1
Brief Summary
This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 30, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
December 1, 2025
November 1, 2025
1.1 years
May 7, 2025
November 27, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
DASS-21 Scale
Measuring severity of Depression, Anxiety and Stress Level. Higher score indicating more severity in experiencing these symptoms
3 to 4 weeks
Mental Health Quality of Life (MHQoL)
Measuring quality of life of individuals. Higher score indicating better quality of life.
3 to 4 weeks
Sleep Quality Scale (SQS)
Measuring Sleep Quality of Individuals with higher score denoting more acute sleep problem
3 to 4 weeks
Study Arms (2)
EL-SHIN THERAPY (CONTROL GROUP A)
NO INTERVENTIONControl Group
EL-SHIN THERAPY (GROUP B)
EXPERIMENTALGroup receiving intervention
Interventions
Participants will be randomly assigned to Group A and Group B. Group A : Attend a talk on Malaysia Tourism + current coping strategies. Group B : EL-SHIN® Therapy + current coping strategies. Duration of therapies: 2 weeks Assessments using (i) DASS-21 (ii) MHQoL (iii) SLEEP QUALITY SCALE (SQS) at baseline, after 1st week \& 2nd weeks for both groups. Assessment will be done on end of 3rd week to see effect when EL-SHIN Therapy Stopped. Group B participants: Attend a workshop on administration of EL-SHIN® Therapy. Will reinitiate EL-SHIN Therapy on the 4th week and assess on the 8th day to see the effect.
Eligibility Criteria
You may qualify if:
- Age: Above 18 yrs old
- DASS-21 scores:
- "Moderately Depressed (Score: 14-20)", "Moderately Anxious (Score: 10-14)" \& "Moderately Stressed (Score: 19-25)"
- Non-Muslim (Due to legal restriction in Malaysia for this religion)
- English literate
- Believers in Creationism
You may not qualify if:
- Muslim (legal restrictions in Malaysia for this religion).
- Non-English literate (research will be conducted in English only).
- Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Monash University Malaysia
Kuala Lumpur, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
AI SHIN LIM, PHD
Monash University Malaysia
Central Study Contacts
AI SHIN LIM
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 30, 2025
Study Start
June 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
December 1, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share